216 related articles for article (PubMed ID: 28193417)
21. Effects of lipophilic emulsifiers on the oral administration of lovastatin from nanostructured lipid carriers: physicochemical characterization and pharmacokinetics.
Chen CC; Tsai TH; Huang ZR; Fang JY
Eur J Pharm Biopharm; 2010 Mar; 74(3):474-82. PubMed ID: 20060469
[TBL] [Abstract][Full Text] [Related]
22. Encapsulation of vitamin D
Lamsen MRL; Wang T; D'Souza D; Dia V; Chen G; Zhong Q
J Food Sci; 2020 Aug; 85(8):2368-2379. PubMed ID: 32691454
[TBL] [Abstract][Full Text] [Related]
23. Rifampicin loaded mannosylated cationic nanostructured lipid carriers for alveolar macrophage-specific delivery.
Song X; Lin Q; Guo L; Fu Y; Han J; Ke H; Sun X; Gong T; Zhang Z
Pharm Res; 2015 May; 32(5):1741-51. PubMed ID: 25407545
[TBL] [Abstract][Full Text] [Related]
24. Preparation, characterization and pharmacokinetic studies of linalool-loaded nanostructured lipid carriers.
Shi F; Zhao Y; Firempong CK; Xu X
Pharm Biol; 2016 Oct; 54(10):2320-8. PubMed ID: 26986932
[TBL] [Abstract][Full Text] [Related]
25. Nanostructured lipid carriers (NLCs) stabilized by natural or synthetic emulsifiers for lutein delivery: Improved physicochemical stability, antioxidant activity, and bioaccessibility.
Shu X; Zhang L; Liao W; Liu J; Mao L; Yuan F; Gao Y
Food Chem; 2023 Mar; 403():134465. PubMed ID: 36358082
[TBL] [Abstract][Full Text] [Related]
26. Nanostructured lipid carriers as a strategy for encapsulation of active plant constituents: Formulation and in vitro physicochemical characterizations.
Chaudhari VS; Murty US; Banerjee S
Chem Phys Lipids; 2021 Mar; 235():105037. PubMed ID: 33400968
[TBL] [Abstract][Full Text] [Related]
27. Nanostructured lipid carriers incorporating prickly pear seed oil for the encapsulation of vitamin A.
AlZahabi S; Sakr OS; Ramadan AA
J Cosmet Dermatol; 2019 Dec; 18(6):1875-1884. PubMed ID: 30784168
[TBL] [Abstract][Full Text] [Related]
28. Preparation of Chitosan-Coated Nanostructured Lipid Carriers (CH-NLCs) to Control Iron Delivery and Their Potential Application to Food Beverage System.
Lee SA; Joung HJ; Park HJ; Shin GH
J Food Sci; 2017 Apr; 82(4):904-912. PubMed ID: 28241098
[TBL] [Abstract][Full Text] [Related]
29. Nanostructured lipid carriers used for oral delivery of oridonin: an effect of ligand modification on absorption.
Zhou X; Zhang X; Ye Y; Zhang T; Wang H; Ma Z; Wu B
Int J Pharm; 2015 Feb; 479(2):391-8. PubMed ID: 25556104
[TBL] [Abstract][Full Text] [Related]
30. Chitosan coated nanostructured lipid carriers (NLCs) for loading Vitamin D: A physical stability study.
Rabelo RS; Oliveira IF; da Silva VM; Prata AS; Hubinger MD
Int J Biol Macromol; 2018 Nov; 119():902-912. PubMed ID: 30063935
[TBL] [Abstract][Full Text] [Related]
31. Physicochemical characterization and in vivo bioluminescence imaging of nanostructured lipid carriers for targeting the brain: apomorphine as a model drug.
Hsu SH; Wen CJ; Al-Suwayeh SA; Chang HW; Yen TC; Fang JY
Nanotechnology; 2010 Oct; 21(40):405101. PubMed ID: 20823498
[TBL] [Abstract][Full Text] [Related]
32. Nanostructured lipid (NLCs) carriers as a bioavailability enhancement tool for oral administration.
Gaba B; Fazil M; Ali A; Baboota S; Sahni JK; Ali J
Drug Deliv; 2015; 22(6):691-700. PubMed ID: 24670099
[TBL] [Abstract][Full Text] [Related]
33. Selenium-coated nanostructured lipid carriers used for oral delivery of berberine to accomplish a synergic hypoglycemic effect.
Yin J; Hou Y; Yin Y; Song X
Int J Nanomedicine; 2017; 12():8671-8680. PubMed ID: 29263662
[TBL] [Abstract][Full Text] [Related]
34. The use of hot and cold high pressure homogenization to enhance the loading capacity and encapsulation efficiency of nanostructured lipid carriers for the hydrophilic antiretroviral drug, didanosine for potential administration to paediatric patients.
Kasongo KW; Müller RH; Walker RB
Pharm Dev Technol; 2012; 17(3):353-62. PubMed ID: 21241166
[TBL] [Abstract][Full Text] [Related]
35. Size-exclusive effect of nanostructured lipid carriers on oral drug delivery.
Li H; Chen M; Su Z; Sun M; Ping Q
Int J Pharm; 2016 Sep; 511(1):524-537. PubMed ID: 27452421
[TBL] [Abstract][Full Text] [Related]
36. Improvement of fluvastatin bioavailability by loading on nanostructured lipid carriers.
El-Helw AR; Fahmy UA
Int J Nanomedicine; 2015; 10():5797-804. PubMed ID: 26396513
[TBL] [Abstract][Full Text] [Related]
37. Preparation and pharmacokinetics of docetaxel based on nanostructured lipid carriers.
Li X; Wang D; Zhang J; Pan W
J Pharm Pharmacol; 2009 Nov; 61(11):1485-92. PubMed ID: 19903373
[TBL] [Abstract][Full Text] [Related]
38. In vitro characterization and growth inhibition effect of nanostructured lipid carriers for controlled delivery of methotrexate.
Abdelbary G; Haider M
Pharm Dev Technol; 2013; 18(5):1159-68. PubMed ID: 21958084
[TBL] [Abstract][Full Text] [Related]
39. Nanostructured lipid carriers (NLCs) for drug delivery and targeting.
Fang CL; Al-Suwayeh SA; Fang JY
Recent Pat Nanotechnol; 2013 Jan; 7(1):41-55. PubMed ID: 22946628
[TBL] [Abstract][Full Text] [Related]
40. Cysteine-Functionalized Nanostructured Lipid Carriers for Oral Delivery of Docetaxel: A Permeability and Pharmacokinetic Study.
Fang G; Tang B; Chao Y; Xu H; Gou J; Zhang Y; Xu H; Tang X
Mol Pharm; 2015 Jul; 12(7):2384-95. PubMed ID: 25974386
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
